Aligos Therapeutics Inc.

23.69
-0.25 (-1.06%)
At close: Jan 30, 2025, 3:59 PM
23.80
0.44%
After-hours Jan 30, 2025, 05:12 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -4.71 -10.59 -92.16 -217.66 -155.79 -564.11
PS Ratio 26.59 73.13 2.71K n/a n/a n/a
PB Ratio 4.48 9.79 64.02 107.37 -125.47 -571.7
P/FCF Ratio -5.23 -12.66 -101.47 -309.53 -164.31 -917.66
P/OCF Ratio -5.23 -12.81 -102.26 -318.13 -174.1 -1.30K
OCF/S Ratio -5.09 -5.71 -26.53 n/a n/a n/a
Debt / Equity Ratio 0.12 0.12 0.08 0.06 -0.22 -1.01
Quick Ratio 5.90 4.03 5.25 8.26 8.70 12.33
Current Ratio 5.90 4.03 5.25 8.26 8.70 12.33
Asset Turnover 0.10 0.09 0.02 n/a n/a n/a
Interest Coverage n/a -59.5 -972.13 -9.28 n/a n/a
Return on Equity (ROE) -0.95 -0.92 -0.69 -0.49 0.81 1.01
Return on Assets (ROA) -0.58 -0.65 -0.55 -0.41 -0.36 -0.13
Return on Capital (ROIC) -0.69 -0.86 -0.65 -0.42 -0.41 -0.14
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 80.24% 73.57% -2.29K% n/a n/a n/a
Net Profit Margin -564.61% -690.63% -2.94K% n/a n/a n/a
Pretax Profit Margin -559.5% -689.87% -2.94K% n/a n/a n/a
Operating Profit Margin -567.5% -701.66% -2.94K% n/a n/a n/a
FCF Margin -508.83% -577.64% -2.67K% n/a n/a n/a
EBITDA Margin -547.74% -675.24% -2.86K% n/a n/a n/a